Balanced news tone
News Sentiment
600267 sentiment intelligence
Zhejiang Hisun Pharmaceutical Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
77/100 classification confidence.
directly relevant articles
high-authority source matches
+5.1% over one week, +14.9% over four weeks, trend inactive, and near fair-value range.
Price to earnings forward of Zhejiang Hisun Pharmaceutical Co., Ltd. Class A – SSE:600267
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Price to earnings forward of Zhejiang Hisun Pharmaceutical Co., Ltd. Class A – SSE:600267
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Jul 2026 13:22
- Source
- TradingView
Haisco Pharmaceutical (600267.SH) announced its 2025 annual performance, with a net profit attributable to shareholders of 541 million yuan, representing a year-on-year decrease of 10.06%.
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Moomoo
Zhejiang Hisun Pharmaceutical Co., Ltd.: Free of COVID-19, Governments Suggest Favipiravir
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2020 07:00
- Source
- Business Wire
Zhejiang Hisun Pharmaceutical Co. Ltd.: Favipiravir Works - Preliminary Clinical Studies Suggest Positive Effects on COVID-19 Patients
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 19 Mar 2020 07:00
- Source
- PR Newswire
PAG acquires control of Hisun BioRay
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Sep 2019 07:00
- Source
- Asset Publishing and Research Limited
China's Zhejiang Hisun picks up new U.S. deal despite FDA troubles
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 10 Aug 2016 07:00
- Source
- Fierce Pharma
Fujifilm in Avigan API license with Zhejiang Hisun Pharmaceuticals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2016 07:00
- Source
- Fierce Pharma
Pfizer & Hisun Pharma To Jointly Develop Off-Patent Generics In China
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Feb 2012 08:00
- Source
- Asian Scientist Magazine